Trial Profile
A Randomised, Controlled, Multicenter Study to Comparing the Effect of Icotinib plus Intercalated Chemotherapy Combination therapy with Icotinib Alone Therapy as First-line Treatment for Patients with Non-Small-Cell Lung Cancer
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 23 Oct 2019
Price :
$35
*
At a glance
- Drugs Icotinib (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 23 Jul 2014 New trial record